PTC Therapeutics to Host Conference Call to Discuss Second Quarter 2024 Financial Results

Rhea-AI Summary

PTC Therapeutics (NASDAQ: PTCT) has announced a webcast conference call to discuss its second quarter 2024 financial results and provide a business update. The call is scheduled for Thursday, August 8, at 4:30 p.m. EDT. Participants can access the call by phone after registering for dial-in details. To avoid delays, it's recommended to dial in 15 minutes before the call starts. The webcast can be accessed on the Investor section of PTC's website. A replay will be available approximately two hours after the call ends and will be archived on the company's website for 30 days.

WARREN, N.J., July 25, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the company will host a webcast conference call to report its second quarter 2024 financial results and provide an update on the company's business and outlook on Thursday, Aug. 8, at 4:30 p.m. EDT.  

To access the call by phone, please click here to register and you will be provided with dial-in details. To avoid delays, we recommend participants dial in to the conference call 15 minutes prior to the start of the call. The webcast conference call can be accessed on the Investor section of the PTC website at https://ir.ptcbio.com/events-presentations. A replay of the call will be available approximately two hours after completion of the call and will be archived on the company's website for 30 days.

About PTC Therapeutics, Inc.  
PTC is a global biopharmaceutical company focused on the discovery, development and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. PTC's ability to innovate to identify new therapies and to globally commercialize products is the foundation that drives investment in a robust and diversified pipeline of transformative medicines. PTC's mission is to provide access to best-in-class treatments for patients who have little to no treatment options. PTC's strategy is to leverage its strong scientific and clinical expertise and global commercial infrastructure to bring therapies to patients. PTC believes this allows it to maximize value for all its stakeholders. To learn more about PTC, please visit us at www.ptcbio.com and follow us on Facebook, Instagram, LinkedIn and Twitter at @PTCBio.

For More Information:  

Investors:  
Kylie O'Keefe  
+1 (908) 300-0691  
kokeefe@ptcbio.com  

Media:  
Jeanine Clemente  
+1 (908) 912-9406  
jclemente@ptcbio.com  

View original content:https://www.prnewswire.com/news-releases/ptc-therapeutics-to-host-conference-call-to-discuss-second-quarter-2024-financial-results-302207070.html

SOURCE PTC Therapeutics, Inc.

FAQ

When will PTC Therapeutics (PTCT) report its Q2 2024 financial results?

PTC Therapeutics will report its second quarter 2024 financial results on Thursday, August 8, 2024, during a webcast conference call at 4:30 p.m. EDT.

How can investors access PTC Therapeutics' (PTCT) Q2 2024 earnings call?

Investors can access the call by phone after registering for dial-in details or via webcast on the Investor section of PTC's website at https://ir.ptcbio.com/events-presentations.

Will there be a replay available for PTC Therapeutics' (PTCT) Q2 2024 earnings call?

Yes, a replay of the call will be available approximately two hours after completion and will be archived on the company's website for 30 days.

What topics will be covered in PTC Therapeutics' (PTCT) Q2 2024 earnings call?

The call will cover PTC Therapeutics' second quarter 2024 financial results and provide an update on the company's business and outlook.